Long-term outcomes of liver transplantation: Diabetes mellitus

Liver Transplantation

Volumn 15, Issue SUPPL. 2, 2009, Pages

  Pageaux, Georges Philippe ^a   Faure, Stéphanie ^a   Bouyabrine, Hassan ^a   Bismuth, Michael ^a   Assenat, Eric ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CORTICOSTEROID; CYCLOSPORIN; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CEREBROVASCULAR DISEASE; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ETHNICITY; FAMILY HISTORY; GLUCOSE INTOLERANCE; GRAFT RECIPIENT; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; ISCHEMIC HEART DISEASE; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; GRAFT SURVIVAL; LONG TERM CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK ASSESSMENT; TIME; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 2; GRAFT SURVIVAL; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LIVER TRANSPLANTATION; LONG-TERM CARE; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 77449144719     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21913     Document Type: Article

References (25)

1. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernández D, et al. New-onset diabetes after transplantation: 2003 international consensus guidelines. Transplantation 2003; 75: S1-S22.
2. Benhamou PY, Penfornis A,. Natural history, prognosis, and management of transplantation-induced diabetes mellitus. Diabetes Metab 2002; 28: 166-175. (Pubitemid 34746950)
3. Baid S, Cosimi AB, Farrell ML, Schoenfeld DA, Feng S, Chung RT, et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72: 1066-1072. (Pubitemid 32924079)
4. Marchetti P,. New-onset diabetes after liver transplantation: from pathogenesis to management. Liver Transpl 2005; 6: 612-620. (Pubitemid 40872898)
5. Pageaux GP, Calmus Y, Boillot O, Ducerf C, Vanlemmens C, Boudjema K, et al. Steroid withdrawal at day 14 after liver transplantation: a double-blind, placebo-controlled study. Liver Transpl 2004; 10: 1454-1460. (Pubitemid 40028376)
6. Boillot O, Mayer DA, Boudjema K, Salizzoni M, Gridelli B, Filipponi F, et al. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study. Liver Transpl 2005; 11: 61-67. (Pubitemid 40124443)
7. Lladõ L, Xiol X, Figueras J, Ramos E, Memba R, Serrano T, et al. Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study. J Hepatol 2006; 44: 710-716.
8. Lerut J, Mathys J, Verbaandert C, Talpe S, Ciccarelli O, Lemaire J, et al. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. Ann Surg 2008; 248: 956-967.
9. Heisel O, Heisel R, Balshaw R, Keown P,. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004; 4: 583-595. (Pubitemid 38523581)
10. Khalili M, Lim JW, Bass N,. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 2004; 10: 349-355. (Pubitemid 38380307)
11. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-1063. (Pubitemid 29458297)
12. Levy G, Villamil F, Samuel D, Sanjuan F, Grazi GL, Wu Y, et al. Results of LIS2T, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation 2004; 77: 1632-1638. (Pubitemid 38780525)
13. Saab S, Shpaner A, Zhao Y, Brito I, Durazo F, Han S, et al. Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation. Am J Transplant 2006; 6: 1890-1895. (Pubitemid 44024961)
14. Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl 2007; 13: 136-144. (Pubitemid 46099983)
15. Hickman IJ, MacDonald GA,. Impact of diabetes on the severity of liver disease. Am J Med 2007; 120: 829-834. (Pubitemid 47451297)
16. McAlister VC, Haddad E, Renouf E, Malthaner RA, Kjaer MS, Gluud LL,. Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 2006; 6: 1578-1585. (Pubitemid 43945797)
17. AlDosary AA, Ramji AS, Elliott TG, Sirrs SM, Thompson DM, Erb SR, et al. Post-liver transplant diabetes mellitus: an association with hepatitis C. Liver Transpl 2002; 8: 356-361. (Pubitemid 34467370)
18. Navasa M,. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996; 25: 64-71. (Pubitemid 26267094)
19. Moon JI, Barbeito R, Faradji RN, Gaynor JJ, Tzakis AG,. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow-up. Transplantation 2006; 82: 1625-1628. (Pubitemid 46035640)
20. Foxton MR, Quaglia A, Muiesan P, Heneghan MA, Portmann B, Norris S, et al. The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C. Am J Transplant 2006; 6: 1922-1929. (Pubitemid 44024965)
21. Cotler SJ, Kallwitz E, TenCate V, Bhushan A, Berkes J, Benedetti E, et al. Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation. Transplantation 2007; 84: 587-591. (Pubitemid 47429038)
22. Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Rosen CB, et al. Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant 2009; 9: 1406-1413.
23. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J,. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73: 901-906. (Pubitemid 34252352)
24. Mannon RB,. Therapeutic management of posttransplant diabetes mellitus. Transplant Rev 2008; 22: 116-124. (Pubitemid 351372916)
25. Dumortier J, Bernard S, Bouffard Y, Boillot O,. Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus. Liver Transpl 2006; 12: 659-664.